| Objective:Ma Yin-observed treatment of influenza virus particles wind heat syndrome (upper respiratory infection), clinical efficacy, exploring silver-anti-virus particles mechanism for clinical use to provide a scientific basis.Method:A positive drug control in parallel, randomized, double-blind clinical study design, Ma Yin-note anti-virus particles Qingrejiedu, China's treatment of pulmonary Liyan cold wind heat syndrome (upper respiratory infection) of clinical efficacy and safety, to carry out the next step Clinical research and provide the basis for application.1 Clinical data clinical data of this study selected 80 cases in Hubei Province Chinese medicine hospital out-patient patients with upper respiratory tract infection as the subjects. One test group and control group of 40 cases. When the two groups of patients with baseline indicators of statistical tests, all p> 0.05, no significant difference, suggesting that randomly into two groups of patients with baseline data are comparable.2 Drug Usage drug use silver-treated group with anti-viral particles, oral, 2 per bag, three times a day. The control group used Yinqiaojiedu particles, oral, 2 per bag, three times a day. During the clinical study maynot be used in other Chinese medicine treatment of influenza, all types ofantibiotics, antipyretic analgesic effect of drugs such as the impact ofdrugs.3.Effect of observation two groups of patients before and aftertreatment for upper respiratory tract infection effects, the bodytemperature of the onset time (from taking the body temperature began todrop 0.5°C is the time required for the onset time), antipyretic onset time(from taking the body temperature began to drop to 37°C The following isthe time required or antipyretic time), TCM-designate of the clinical signsand symptoms score.4.Statistical methods statistical analysis of statistical methods usedSAS6.12 statistical analysis software. All the statistics to take bilateral test,P value of less than or equal to 0.05 by the test was considered astatistically significant difference.Results:1 Clinical Evaluation1.1 on the two groups of patients with respiratory infections effects of thetreatment group and control group of upper respiratory tract infection havesignificant effects, the treatment group markedly effective rate of 80.0percent, the rate was 95.0 percent, the control group markedly effectiverate of 77.5 percent, and the total Efficiency of92.5 percent. 1.2 Two groups of patients with body temperature and antipyretic effect from time to compare the two groups are obvious effect of the treatment group average body temperature of the onset, antipyretic time were 13.63 disabilities 8.75,24.13 with 12.25 hours, the control group average of onset, antipyretic time 15.05 disabilities were 10.45,25.7 5 with 15.26 hours. Difference between the two groups have significant statistical significance (P <0.01), that the treatment group in alleviating the symptoms of fever effect of significantly higher.1.3 TCM Syndrome effects of Chinese medicine syndrome are two obvious effects, the treatment group markedly effective rate of 82.5 percent, the rate was 95.0percent; control group markedly effective rate of 77.5 percent, the rate was 92.5 percent.1.4 TCM main symptoms and signs effects of the two groups before and after treatment in patients with symptoms of the Chinese total score margin, the difference was not significant.Conclusion:The clinical study used a randomized, double-blind, parallel positive drug control, clinical research methods, the results show that Ma Yin-treatment of influenza virus particles wind heat syndrome (upper respiratory infection) and the effect of the control group Yinqiaojiedu particles with no statistical difference between a non - Poor efficiency of the. There was no bad treatment of the incident. Therefore suggested that Ma Yin-treatment of influenza virus particles wind heat syndrome (upper respiratory infection) safe and effective drugs. |
PDF Full Text Request